Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:07 2024-09-13 am EDT			5-day change	1st Jan Change
1,633.50 ^GBX	-0.31%		-1.09%	+12.64%

07:28pm	Moderna's Faces 'Material Headwinds' on RSV, COVID, RBC Says	MT
06:41pm	GSK Bets on Blood-Cancer Drug Comeback Amid Oncology Push	DJ

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	88,051	66,801	80,458	58,381	59,112	66,834	-	-
Change	-	-24.13%	20.44%	-27.44%	1.25%	13.06%	-	-
Enterprise Value (EV) ¹	113,773	87,581	100,296	75,578	74,152	78,780	75,384	71,313
Change	-	-23.02%	14.52%	-24.65%	-1.89%	6.24%	-4.31%	-5.4%
P/E ratio	19.2x	11.8x	18.6x	3.93x	11.9x	12.8x	10.5x	9.42x
PBR	7.35x	4.58x	5.34x	5.47x	4.4x	4.23x	3.47x	2.86x
PEG	-	0.5x	-0.8x	0x	-0.2x	2.61x	0.5x	0.8x
Capitalization / Revenue	2.61x	1.96x	2.36x	1.99x	1.95x	2.11x	2x	1.89x
EV / Revenue	3.37x	2.57x	2.94x	2.58x	2.45x	2.49x	2.26x	2.01x
EV / EBITDA	9.51x	9.19x	8.85x	7.23x	6.37x	7.38x	6.45x	5.6x
EV / EBIT	12.7x	9.83x	11.4x	9.27x	8.44x	8.54x	7.48x	6.37x
EV / FCF	22.4x	16.2x	22.6x	12.1x	13.6x	14.7x	10.8x	9.37x
FCF Yield	4.46%	6.17%	4.42%	8.28%	7.36%	6.81%	9.25%	10.7%
Dividend per Share ²	1	1	1	0.6125	0.58	0.6032	0.6399	0.6807
Rate of return	4.5%	5.96%	4.98%	4.26%	4%	3.68%	3.91%	4.15%
EPS ²	1.158	1.426	1.082	3.662	1.216	1.276	1.562	1.739
Distribution rate	86.4%	70.1%	92.4%	16.7%	47.7%	47.3%	41%	39.1%
Net sales ¹	33,754	34,099	34,114	29,324	30,328	31,639	33,391	35,399
EBITDA ¹	11,968	9,530	11,330	10,449	11,635	10,671	11,685	12,744
EBIT ¹	8,972	8,906	8,806	8,151	8,786	9,222	10,081	11,195
Net income ¹	4,645	5,749	4,385	14,956	4,928	5,149	6,442	7,158
Net Debt ¹	25,722	20,780	19,838	17,197	15,040	11,946	8,550	4,479
Reference price ²	22.24	16.78	20.08	14.38	14.50	16.38	16.38	16.38
Nbr of stocks (in thousands)	3,959,572	3,982,185	4,006,383	4,060,999	4,076,145	4,078,961	-	-
Announcement Date	2/5/20	2/3/21	2/9/22	2/1/23	1/31/24	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
GSK PLC	12.84x	2.49x	7.38x	+3.68%	87.38B
ELI LILLY AND COMPANY	60.29x	18.66x	45.34x	+0.56%	842B
NOVO NORDISK A/S	40.25x	14.02x	28.55x	+1.25%	599B
JOHNSON & JOHNSON	21.08x	4.56x	12.93x	+2.84%	396B
ABBVIE INC.	37.76x	7.15x	15.45x	+3.21%	343B
MERCK & CO., INC.	15.37x	4.89x	11.2x	+2.67%	292B
ROCHE HOLDING AG	15.61x	3.74x	9.77x	+3.74%	248B
ASTRAZENECA PLC	28.22x	5.08x	15.05x	+1.97%	244B
NOVARTIS AG	21.4x	4.93x	12.49x	+3.28%	233B
AMGEN INC.	50.85x	6.85x	12x	+2.78%	177B
Average	30.37x	7.24x	17.02x	+2.60%	346.28B
Weighted average by Cap.	36.55x	9.98x	23.32x	+2.08%